Geode Capital Management’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.89M | Buy |
|
|||||
|
2025
Q1 | $6.03M | Buy |
|
|||||
|
2024
Q4 | $9.42M | Buy |
|
|||||
|
2024
Q3 | $12.8M | Buy |
|
|||||
|
2024
Q2 | $13.3M | Sell |
|
|||||
|
2024
Q1 | $18.6M | Buy |
|
|||||
|
2023
Q4 | $17M | Buy |
|
|||||
|
2023
Q3 | $13.1M | Buy |
|
|||||
|
2023
Q2 | $14.2M | Buy |
|
|||||
|
2023
Q1 | $11.2M | Buy |
|
|||||
|
2022
Q4 | $7.63M | Buy |
|
|||||
|
2022
Q3 | $6.18M | Buy |
|
|||||
|
2022
Q2 | $6.18M | Buy |
|
|||||
|
2022
Q1 | $10M | Sell |
|
|||||
|
2021
Q4 | $13.9M | Sell |
|
|||||
|
2021
Q3 | $19.1M | Buy |
|
|||||
|
2021
Q2 | $13M | Buy |
|
|||||
|
2021
Q1 | $14.7M | Buy |
|
|||||
|
2020
Q4 | $14.1M | Buy |
|
|||||
|
2020
Q3 | $11.6M | Buy |
|
|||||
|
2020
Q2 | $9.92M | Buy |
|
|||||
|
2020
Q1 | $1.2M | Buy |
|
|||||
|
2019
Q4 | $918K | Buy |
|
|||||
|
2019
Q3 | $808K | Buy |
|
|||||
|
2019
Q2 | $127K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $11K | Hold |
|
|||||
|
2017
Q2 | $12K | Sell |
|
|||||
|
2017
Q1 | $17K | Buy |
|
|||||
|
2016
Q4 | $31K | Buy |
|
|||||
|
2016
Q3 | $36K | Buy |
|
|||||
|
2016
Q2 | $65K | Hold |
|
|||||
|
2016
Q1 | $55 | Buy |
|